1/24
05:09 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
1/15
07:46 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/13
09:03 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its price target raised by analysts at Wedbush from $48.00 to $50.00. They now have an "outperform" rating on the stock.
Medium
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its price target raised by analysts at Wedbush from $48.00 to $50.00. They now have an "outperform" rating on the stock.
1/12
07:30 am
knsa
Kiniksa Pharmaceuticals Provides Corporate Update
Medium
Report
Kiniksa Pharmaceuticals Provides Corporate Update
1/7
04:01 pm
knsa
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference
12/2
07:33 pm
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $48.00 price target on the stock.
Low
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $48.00 price target on the stock.
11/12
04:01 pm
knsa
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London
Low
Report
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London